Statin Barriers

The article defines clinical inertia broadly as clinicians failing to intensify or adjust treatment when therapeutic targets are unmet. The correction notice provides no further methodological or results detail about clinical inertia beyond the study description. Deferral to another healthcare professional was the most common documented reason for statin undertreatment. Statin intolerance was documented in 15.8% of patients. Clinical inertia was documented in 9.0% of patients, and patient refusal in 6.4%. The corrected article investigates the magnitude of clinical inertia among adult patients with asthma. Guidelines recommend statins for this age group with T1D regardless of baseline LDL.